# Meclofenoxate
*Source: https://psychonautwiki.org/wiki/Meclofenoxate*

## Dosage & Duration

### Oral

**Dosage:**
- Threshold: 50 mg
- Light: 50 - 200 mg
- Common: 400 - 800 mg
- Strong: 800 - 1000 mg
- Heavy: 600 mg +

**Duration:**

**Meclofenoxate** , also known as Centrophenoxine or Lucidril is a nootropic that acts as a precursor to [choline](https://psychonautwiki.org/wiki/Choline) . It is a an ester of Dimethylaminoethanol and para-chlorophenoxyacetic acid.

## History and culture

Mecolofenoxate was developed in 1959 at the French National Scientific Research Center. [*[citation needed](https://psychonautwiki.org/wiki/Citation_needed)*] Meclofenoxate has been tested as alzheimers treatment. Additionally it has been shown to invrease the life span of mice by up to 29.5%.

## Pharmacology

A portion of Meclofenoxate breaks down into [DMAE](http://en.wikipedia.org/wiki/Dimethylethanolamine) and [pCPA](http://en.wikipedia.org/wiki/4-Chlorophenoxyacetic_acid) . DMAE is then converted to [choline](https://psychonautwiki.org/wiki/Choline) .

## Subjective effects

***Disclaimer:** The effects listed below cite the [Subjective Effect Index](https://psychonautwiki.org/wiki/Subjective_effect_index) ( **SEI** ), an open research literature based on anecdotal user reports and the personal analyses of [PsychonautWiki](https://psychonautwiki.org/wiki/PsychonautWiki) [contributors](https://psychonautwiki.org/wiki/Special:TopUsers) . As a result, they should be viewed with a healthy degree of skepticism.*

*It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. *Likewise, **adverse effects** become increasingly likely with higher doses and may include **addiction, severe injury, or death*** ☠.*
### Physical effects
 
- - **[Bodily control enhancement](https://psychonautwiki.org/wiki/Bodily_control_enhancement)**
- **[Body odor alteration](https://psychonautwiki.org/wiki/Body_odor_alteration)** - This can be caused in some populations, especially those suffering from trimethylaminuria. [Choline](https://psychonautwiki.org/wiki/Choline) (a metabolite of meclofenoxate) is a precursor to trimethylamine, which those with trimethylaminuria are not able to easily break down, oftening resulting in smelling similar to fish.
- **[Dizziness](https://psychonautwiki.org/wiki/Dizziness)**
- **[Headaches](https://psychonautwiki.org/wiki/Headaches)**
- **[Muscle tension](https://psychonautwiki.org/wiki/Muscle_tension)**
- **[Nausea](https://psychonautwiki.org/wiki/Nausea)**
- **[Stamina enhancement](https://psychonautwiki.org/wiki/Stamina_enhancement)**
- **[Stimulation](https://psychonautwiki.org/wiki/Stimulation)** - The stimulation which meclofenoxate presents can be considered as primarily subtle and similar to that of [caffeine](https://psychonautwiki.org/wiki/Caffeine) .
- **[Teeth grinding](https://psychonautwiki.org/wiki/Teeth_grinding)** ### Cognitive effects
 
- - **[Anxiolytic](https://psychonautwiki.org/wiki/Anxiolytic)**
- **[Depression](https://psychonautwiki.org/wiki/Depression)**
- **[Dream potentiation](https://psychonautwiki.org/wiki/Dream_potentiation)**
- **[Focus enhancement](https://psychonautwiki.org/wiki/Focus_enhancement)**
- **[Visual acuity enhancement](https://psychonautwiki.org/wiki/Visual_acuity_enhancement)**
- **[Olfactory intensification](https://psychonautwiki.org/wiki/Olfactory_intensification)**
- **[Insomnia](https://psychonautwiki.org/wiki/Insomnia)**
- **[Memory enhancement](https://psychonautwiki.org/wiki/Memory_enhancement)**
- **[Mindfulness](https://psychonautwiki.org/wiki/Mindfulness)**
- **[Motivation enhancement](https://psychonautwiki.org/wiki/Motivation_enhancement)**
- **[Wakefulness](https://psychonautwiki.org/wiki/Wakefulness)** - In comparison to [citicoline](https://psychonautwiki.org/wiki/Citicoline) , meclofenoxate manifests itself primarily in a physically stimulating manner over a mental stimulation.
### Experience reports

There are currently no anecdotal reports which describe the effects of this compound within our [experience index](https://psychonautwiki.org/wiki/Experience_index) . Additional experience reports can be found here:

- [Erowid Experience Vaults: Meclofenoxate](https://www.erowid.org/experiences/subs/exp_Meclofenoxate.shtml)

## Toxicity and harm potential

**Warning:** contraindications for Meclofenoxate include [depression](http://en.wikipedia.org/wiki/depression) , [mania](http://en.wikipedia.org/wiki/mania) , [epilepsy](http://en.wikipedia.org/wiki/epilepsy) and [convulsions](http://en.wikipedia.org/wiki/convulsions) .

Meclofenoxate is non-addictive, is not known to cause harm, and has an extremely low toxicity relative to dose. Similar to many other [nootropic](https://psychonautwiki.org/wiki/Nootropic) substances, there are relatively few physical side effects associated with acute choline exposure. Various studies have shown that in reasonable doses in a particular context, it presents no negative cognitive, psychiatric or toxic physical consequences of any sort.

Regardless, it is strongly recommended that one is familiar with and uses [harm reduction practices](https://psychonautwiki.org/wiki/Responsible_drug_use) when using this substance.

### Tolerance and addiction potential

### Dangerous interactions

In vitro studies of meclofenoxate showed inhibition of total MAO, MAO A and MAO B in rat brains. Meclofenoxate and [MAOIs](https://psychonautwiki.org/wiki/MAOIs) are a potentially dangerous combination. It is likely that MAOIs could increase the effects of meclofenoxate unpredictably. Taking this chemical while on prescription MAOIs is strongly discouraged.

## Legal issues

- **United States** - Meclofenoxate is completely legal to purchase in the United States as a dietary supplement.

## See also

- [alpha-GPC](https://psychonautwiki.org/wiki/Alpha-GPC)
- [Citicoline](https://psychonautwiki.org/wiki/Citicoline)
- [Choline](https://psychonautwiki.org/wiki/Choline)
- [Nootropic](https://psychonautwiki.org/wiki/Nootropic)

## External links

- [Meclofenoxate (Wikipedia)](https://en.wikipedia.org/wiki/Meclofenoxate)
- [Meclofenoxate (Isomer Design)](https://isomerdesign.com/PiHKAL/explore.php?id=11475)
- [Meclofenoxate (Erowid Vault)](https://www.erowid.org/smarts/meclofenoxate/)
- [Centrophenoxine (Examine)](https://examine.com/supplements/centrophenoxine/)

## References
1. ↑ Malík, Matěj; Tlustoš, Pavel (2022-08-17). "Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs".*Nutrients*.**14**(16): 3367.[doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.3390/nu14163367](//doi.org/10.3390%2Fnu14163367).[ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number)[2072-6643](//www.worldcat.org/issn/2072-6643).[PMID](http://en.wikipedia.org/wiki/PubMed_Identifier)[36014874](//www.ncbi.nlm.nih.gov/pubmed/36014874).
2. ↑ Hochschild, R. (1973). "Effect of dimethylaminoethyl p-chlorophenoxyacetate on the life span of male swiss webster albino mice".*Experimental Gerontology*.**8**(4): 177–183.[doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1016/0531-5565(73)90024-7](//doi.org/10.1016%2F0531-5565%2873%2990024-7).
3. ↑ ["Uses of Lucimax"](https://www.vinmec.com/en/pharmaceutical-information/use-medicines-safely/uses-of-lucimax/).*Vinmec*. 2012-11-30. Retrieved 2024-03-14.
4. ↑ SL, Stancheva; LG, Alova.["[Effect of centrophenoxine, piracetam and aniracetam on the monoamine oxidase activity in different brain structures of rats]"](https://pubmed.ncbi.nlm.nih.gov/3137089/).*Farmakologiia i toksikologiia*. Farmakol Toksikol.**51**(3).[ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number)[0014-8318](//www.worldcat.org/issn/0014-8318).[PMID](http://en.wikipedia.org/wiki/PubMed_Identifier)[3137089](//www.ncbi.nlm.nih.gov/pubmed/3137089). Retrieved 2024-03-15.NewPP limit report Cached time: 20251218075545 Cache expiry: 1209600 Dynamic content: false Complications: [] [SMW] In‐text annotation parser time: 0.019 seconds CPU time usage: 0.222 seconds Real time usage: 0.429 seconds Preprocessor visited node count: 1113/1000000 Post‐expand include size: 48535/2097152 bytes Template argument size: 5341/2097152 bytes Highest expansion depth: 12/40 Expensive parser function count: 0/100 Unstrip recursion depth: 0/20 Unstrip post‐expand size: 6052/5000000 bytes Lua time usage: 0.130/7 seconds Lua virtual size: 7.41 MB/50 MB Lua estimated memory usage: 0 bytes ExtLoops count: 11Transclusion expansion time report (%,ms,calls,template) 100.00% 341.204 1 -total 35.26% 120.307 1 Template:Citation_needed 32.83% 112.033 3 Template:Cite_journal 21.86% 74.581 1 Template:Fix 20.34% 69.402 2 Template:Category_handler 12.69% 43.306 1 Template:SubstanceBox/Meclofenoxate 12.15% 41.456 1 Template:SubstanceBox 6.19% 21.133 1 Template:Effects/base 5.28% 18.013 1 Template:Cite_web 5.17% 17.638 1 Template:Effect_list